180 related articles for article (PubMed ID: 25296595)
21. A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.
Boccia RV; Cosgriff TM; Headley DL; Badarinath S; Dakhil SR
Clin Colorectal Cancer; 2010 Apr; 9(2):102-7. PubMed ID: 20378504
[TBL] [Abstract][Full Text] [Related]
22. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.
Chibaudel B; Maindrault-Goebel F; Lledo G; Mineur L; André T; Bennamoun M; Mabro M; Artru P; Carola E; Flesch M; Dupuis O; Colin P; Larsen AK; Afchain P; Tournigand C; Louvet C; de Gramont A
J Clin Oncol; 2009 Dec; 27(34):5727-33. PubMed ID: 19786657
[TBL] [Abstract][Full Text] [Related]
23. [Combination of hepatic arterial infusion therapy and FOLFOX for colorectal cancer with multiple unresectable liver metastases causing severe liver dysfunction].
Suto T; Sato T; Mori N; Takano N; Ishiyama K; Sakurai N; Saito K; Iizawa H; Ikeda E
Gan To Kagaku Ryoho; 2009 Jan; 36(1):71-6. PubMed ID: 19151566
[TBL] [Abstract][Full Text] [Related]
24. Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial.
Ducreux M; Malka D; Mendiboure J; Etienne PL; Texereau P; Auby D; Rougier P; Gasmi M; Castaing M; Abbas M; Michel P; Gargot D; Azzedine A; Lombard-Bohas C; Geoffroy P; Denis B; Pignon JP; Bedenne L; Bouché O;
Lancet Oncol; 2011 Oct; 12(11):1032-44. PubMed ID: 21903473
[TBL] [Abstract][Full Text] [Related]
25. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
26. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
Goldberg RM; Tabah-Fisch I; Bleiberg H; de Gramont A; Tournigand C; Andre T; Rothenberg ML; Green E; Sargent DJ
J Clin Oncol; 2006 Sep; 24(25):4085-91. PubMed ID: 16943526
[TBL] [Abstract][Full Text] [Related]
27. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
28. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
André T; Bensmaine MA; Louvet C; François E; Lucas V; Desseigne F; Beerblock K; Bouché O; Carola E; Merrouche Y; Morvan F; Dupont-André G; de Gramont A
J Clin Oncol; 1999 Nov; 17(11):3560-8. PubMed ID: 10550155
[TBL] [Abstract][Full Text] [Related]
29. [Study on the damage of liver in patients with SARS].
Guan YJ; Tang XP; Yin CB; Yi ZQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
[TBL] [Abstract][Full Text] [Related]
30. Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats.
Usmani A; Mujahid M; Khushtar M; Siddiqui HH; Rahman MA
J Complement Integr Med; 2016 Sep; 13(3):295-300. PubMed ID: 27101559
[TBL] [Abstract][Full Text] [Related]
31. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
Hwang JJ
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
[TBL] [Abstract][Full Text] [Related]
32. A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancer.
Kato K; Inaba Y; Tsuji Y; Esaki T; Yoshioka A; Mizunuma N; Mizuno T; Kusaba H; Fujii H; Muro K; Shimada Y; Shirao K
Jpn J Clin Oncol; 2011 Jan; 41(1):63-8. PubMed ID: 20819832
[TBL] [Abstract][Full Text] [Related]
33. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
34. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.
Santini D; Vincenzi B; Massacesi C; Picardi A; Gentilucci UV; Esposito V; Liuzzi G; La Cesa A; Rocci L; Marcucci F; Montesarchio V; Groeger AM; Bonsignori M; Tonini G
Anticancer Res; 2003; 23(6D):5173-9. PubMed ID: 14981985
[TBL] [Abstract][Full Text] [Related]
35. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
Douillard JY; Siena S; Cassidy J; Tabernero J; Burkes R; Barugel M; Humblet Y; Bodoky G; Cunningham D; Jassem J; Rivera F; Kocákova I; Ruff P; Błasińska-Morawiec M; Šmakal M; Canon JL; Rother M; Oliner KS; Wolf M; Gansert J
J Clin Oncol; 2010 Nov; 28(31):4697-705. PubMed ID: 20921465
[TBL] [Abstract][Full Text] [Related]
36. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
37. Raltitrexed-based chemotherapy for advanced colorectal cancer.
Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
[TBL] [Abstract][Full Text] [Related]
38. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM
Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
40. High dose vitamin D supplementation is associated with an improvement in serum markers of liver function.
Tavakoli H; Rostami H; Avan A; Bagherniya M; Ferns GA; Khayyatzadeh SS; Ghayour-Mobarhan M
Biofactors; 2019 May; 45(3):335-342. PubMed ID: 30761636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
